WHO inspection observations – Pharma GMP

Common Deficiencies Observed in WHO GMP Inspections

digi — Tue, 27 May 2025 05:42:09 +0000

Common Deficiencies Observed in WHO GMP Inspections Top GMP Deficiencies Commonly Identified During WHO Inspections WHO GMP inspections are globally recognized for their rigor and structured evaluation of pharmaceutical manufacturing facilities. For companies seeking WHO prequalification, understanding the common deficiencies observed during WHO GMP inspections is crucial for proactive risk mitigation and audit preparedness. This...

WHO GMP Inspection Guidelines: Scope and Structure Explained

digi — Mon, 26 May 2025 06:00:47 +0000

WHO GMP Inspection Guidelines: Scope and Structure Explained Decoding the WHO GMP Inspection Guidelines: Scope and Structural Overview The World Health Organization (WHO) plays a pivotal role in setting global standards for pharmaceutical manufacturing. Its GMP inspection guidelines, particularly as outlined in WHO Technical Report Series (TRS) 986 and 961, are used worldwide to assess...